Sign up for free newsletter



BTIG expands healthcare research coverage

BTIG, a financial services firm specialising in institutional trading and related brokerage services, has appointed Hartaj Singh as a director and biotechnology analyst.

Singh has broad experience in the field of healthcare, having covered global biotechnology and international pharmaceutical stocks during his nine years as both a sell- and buy-side research analyst.
At BTIG, Hartaj will focus on US biotechnology firms and other global biotechnology and pharmaceuticals stocks that are in their competitive landscape.
“Hartaj’s insight in the biotechnology sector, his understanding sentiment and his analysis of both long and short strategies will provide yet another differentiating factor for our research effort,” says Scott Kovalik, co-founder of BTIG. “As we expand our research offering, it is key that we bring on top talent to match the level of expertise that our current research team affords our clients, and Hartaj certainly meets that high standard.”
Hartaj is returning to the sell-side after several years as a buy-side analyst at Visium Asset Management, where he covered the European and international pharmaceutical and biotechnology sectors. Prior to that, at Lehman Brothers, Hartaj assisted in the re-launch of the US large-cap biotechnology research franchise. In addition, Hartaj assisted healthcare clients with critical strategic, clinical and operational projects as a managing consultant with Navigant Consulting’s life sciences practice from 2003 to 2005. Prior to working on the sell- and buy-side, Hartaj worked for almost 10 years in the industry with experience in clinical drug development, sales and marketing and business development.
Hartaj’s hire is BTIG’s latest move to expand its research offerings, which now includes a global strategist, a technical strategist, seven publishing analysts covering the consumer, financials, healthcare, media, entertainment, cable and satellite, internet, communications equipment, telecom services and special situations sectors. This month BTIG also hired Dane Leone as a diagnostics and life sciences analyst.

from Institutional Asset Manager

DA Davidson hires managing director

Fri 24/03/2017 - 09:05

AXA promotes two senior execs

Fri 24/03/2017 - 09:02

Edison appoints head of Australasia

Thu 23/03/2017 - 09:32

from our other sites

INREV CEO to step down

Mon 27/03/2017 - 14:03

1 week 23 hours from now - Hong Kong
1 week 1 day from now - Toronto
1 week 3 days from now - Shanghai
Sun, 09/04/2017   - Dubai
Mon, 15/05/2017   - London
IKONIC Fund Services Ltd.
Tue, 29/11/2016 - 11:28
Backstop Solutions Group
Tue, 08/11/2016 - 17:44
The Gemini Companies
Mon, 17/10/2016 - 11:51
other gfm publications